Caricamento...
Cost recovery by Health Canada and drug safety: a time-series analysis
BACKGROUND: In 1995, Health Canada started collecting fees from pharmaceutical companies for various drug regulatory activities. This study investigated whether this change in the source of revenue affected the postmarket safety of drugs. METHODS: A list of all new active substances approved in the...
Salvato in:
| Pubblicato in: | CMAJ Open |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Joule Inc. or its licensors
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6201714/ https://ncbi.nlm.nih.gov/pubmed/30337472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9778/cmajo.20180146 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|